Oncostatin M and the interleukin-6 and soluble interleukin-6 receptor complex regulate alpha1-antichymotrypsin expression in human cortical astrocytes.
about
The zinc finger protein Gfi-1 can enhance STAT3 signaling by interacting with the STAT3 inhibitor PIAS3BCL3 is induced by IL-6 via Stat3 binding to intronic enhancer HS4 and represses its own transcriptionInterleukin-6-type cytokine signalling through the gp130/Jak/STAT pathwayA complex of nuclear factor I-X3 and STAT3 regulates astrocyte and glioma migration through the secreted glycoprotein YKL-40Oncostatin M promotes excitotoxicity by inhibiting glutamate uptake in astrocytes: implications in HIV-associated neurotoxicityThe PPARdelta agonist GW501516 suppresses interleukin-6-mediated hepatocyte acute phase reaction via STAT3 inhibitionGenetic risk factors in Alzheimer's diseaseNuclear factor-1-X regulates astrocyte-specific expression of the alpha1-antichymotrypsin and glial fibrillary acidic protein genes.The unique transcriptional activation domain of nuclear factor-I-X3 is critical to specifically induce marker gene expression in astrocytes.Oncostatin M binds to extracellular matrix in a bioactive conformation: implications for inflammation and metastasisRelB/p50 complexes regulate cytokine-induced YKL-40 expressionA role for apoE in regulating the levels of alpha-1-antichymotrypsin in the aging mouse brain and in Alzheimer's disease.Nuclear factor I isoforms regulate gene expression during the differentiation of human neural progenitors to astrocytesSphingosine-1-phosphate inhibits IL-1-induced expression of C-C motif ligand 5 via c-Fos-dependent suppression of IFN-β amplification loop.EGF regulates plasminogen activator inhibitor-1 (PAI-1) by a pathway involving c-Src, PKCdelta, and sphingosine kinase 1 in glioblastoma cells.K63-linked polyubiquitination of transcription factor IRF1 is essential for IL-1-induced production of chemokines CXCL10 and CCL5.Biomarkers in Alzheimer's disease: a review.Recent progress in omics-driven analysis of MS to unravel pathological mechanisms.Discovery and validation of information theory-based transcription factor and cofactor binding site motifs.The inhibition of interleukin-6-dependent STAT activation by mitogen-activated protein kinases depends on tyrosine 759 in the cytoplasmic tail of glycoprotein 130.Astrocyte-specific expression of the alpha1-antichymotrypsin and glial fibrillary acidic protein genes requires activator protein-1.Co-activator SRC-1 is dispensable for transcriptional control by STAT3.Alpha 1-antichymotrypsin/SerpinA3 is a novel target of orphan nuclear receptor Nur77.Duration of alpha 1-antichymotrypsin gene activation by interleukin-1 is determined by efficiency of inhibitor of nuclear factor kappa B alpha resynthesis in primary human astrocytes.Analysis of Stat3 (signal transducer and activator of transcription 3) dimerization by fluorescence resonance energy transfer in living cells.Differential effects of oncostatin M and leukaemia inhibitory factor expression in astrocytoma cells.Oncostatin M-mediated growth inhibition of human glioblastoma cells does not depend on stat3 or on mitogen-activated protein kinase activation.Effects of pro-inflammatory cytokines on apolipoprotein E secretion by a human astrocytoma cell line (CCF-STTG1).Mechanism of plasminogen activator inhibitor-1 regulation by oncostatin M and interleukin-1 in human astrocytesComparison of inflammatory and acute-phase responses in the brain and peripheral organs of the ME7 model of prion diseaseThe transcriptional response of skin to fluorescent light exposure in viviparous (Xiphophorus) and oviparous (Danio, Oryzias) fishes.Astrocyte- and hepatocyte-specific expression of genes from the distal serpin subcluster at 14q32.1 associates with tissue-specific chromatin structures.A novel mechanism of tissue inhibitor of metalloproteinases-1 activation by interleukin-1 in primary human astrocytes.Novel role of the nociceptin system as a regulator of glutamate transporter expression in developing astrocytes.Interleukin-6/soluble interleukin-6 receptor complex reduces infarct size via inhibiting myocardial apoptosis.Oncostatin-M induction of vascular endothelial growth factor expression in astroglioma cells.STAT3 signaling after traumatic brain injury.Oncostatin M regulation of interleukin-6 expression in astrocytes: biphasic regulation involving the mitogen-activated protein kinases ERK1/2 and p38.
P2860
Q24290464-B295F1DE-6ADF-4E2C-86BA-72393D78BA99Q24338268-AB16A005-883D-422A-8713-AB2E52EA0A5BQ24531184-93CECA49-1E1A-4B29-AC63-09C4AA7C2004Q24624033-55C3981D-B38F-4271-B2D4-513164028F96Q28396730-CDCB9EFD-4148-4D75-AEC5-47A7D6890BD6Q28572346-E93A80EF-47F5-47A9-AA55-346B398315EFQ33588353-467A4626-DB04-495E-96D2-1C76882E720EQ34505563-9DCCE1AE-6C6B-4367-A3E0-4F62A4156477Q34606277-4C4E1FFF-843D-4161-A69D-BD4399724715Q35084743-D816C20B-5568-4165-A572-0B9F65430A06Q35164695-63C35C64-6336-4732-A7F2-D26B85DAA0E6Q35787924-0A6FF4E7-EAF1-4E98-9C6F-90D7A9B31996Q36158401-FB8404BE-1B82-43CC-B9D5-5C014E599A4DQ36299846-31852D53-B172-41AE-B258-289082878475Q37364683-F9D3B880-3F63-4E29-8422-9528F28211F5Q37686404-4F9E380F-D297-4388-B7AD-F3AD2A3852DBQ38027541-333E3371-6C94-45AD-8765-B67E74B36E64Q38140023-F2D0CB31-915C-40CA-B51E-CA215AC35F53Q38289980-199C123B-8107-477E-92A1-0E093F233606Q38313302-2DF99E34-D729-4F39-ACB7-EF858E7C7BCAQ38318550-66C0EC32-37A8-4E79-8188-D2C7926A278FQ39885852-AFA33A3E-1D26-4EEB-B6A0-3A8F8C4C645EQ40016838-6A6A6323-D124-4655-AB13-A9BFAE3A86E5Q40462919-40A84F9D-75E2-45AF-A70B-79729A32AA13Q40634557-6B2CB94E-5A57-4CB2-B622-D75E9B22EC5AQ40815412-7BB071D4-EDC2-4DE3-A89D-F7C700D48FF5Q40862775-70F4A41E-AE63-4403-8162-48F96FA2C935Q40898552-53426FD3-4918-4E3E-8826-ADD42D18E425Q42157642-66967D71-DBFA-4AD1-9DB1-2C9CFA2A12A2Q42709847-CFC258BA-0FC0-4124-AA19-2340AC587B4EQ42778078-B51AF021-9C64-445F-B9FC-E04250950B0FQ43056147-F43E2E3B-EC89-4092-8FBF-DD3818046F5BQ44923694-1A0B5B1C-1BF5-441F-A359-FABB79C7EBDEQ45067354-70EB90E5-6470-4353-ADB5-710751B093B9Q46628430-5BC69423-97C4-414E-AF27-B64FCCF62F6AQ48152085-0AFEFC6B-A6A2-4119-A315-3AD38BE2E963Q48796477-7392B83D-EE88-4D45-8FBE-BC8236C2F8C8Q55475407-442F0E35-93C5-408F-8DBB-1E0EE63E01AC
P2860
Oncostatin M and the interleukin-6 and soluble interleukin-6 receptor complex regulate alpha1-antichymotrypsin expression in human cortical astrocytes.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Oncostatin M and the interleuk ...... in human cortical astrocytes.
@en
Oncostatin M and the interleuk ...... in human cortical astrocytes.
@nl
type
label
Oncostatin M and the interleuk ...... in human cortical astrocytes.
@en
Oncostatin M and the interleuk ...... in human cortical astrocytes.
@nl
prefLabel
Oncostatin M and the interleuk ...... in human cortical astrocytes.
@en
Oncostatin M and the interleuk ...... in human cortical astrocytes.
@nl
P2093
P2860
P356
P1476
Oncostatin M and the interleuk ...... in human cortical astrocytes.
@en
P2093
P2860
P304
P356
10.1074/JBC.273.7.4112
P407
P577
1998-02-01T00:00:00Z